| Peptide sequence: | SNFLNCYVSGFHPSDIEVDLLK | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genes: | B2M | ||||||||||||||||||||
| Dataset | Samples | Median log2( Intensity ) | Decile | ||||||
|---|---|---|---|---|---|---|---|---|---|
| uSP | 150 (100.0%) | 31.22 | 1 | ||||||
| uEV-P20 | 149 (98.7%) | 30.2 | 1 | ||||||
| uEV-P150 | 109 (71.2%) | 25.74 | 1 | ||||||
© 2022 Dr. Kislinger lab
| Peptide sequence: | SNFLNCYVSGFHPSDIEVDLLK | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genes: | B2M | ||||||||||||||||||||
| Dataset | Samples | Median log2( Intensity ) | Decile | ||||||
|---|---|---|---|---|---|---|---|---|---|
| uSP | 150 (100.0%) | 31.22 | 1 | ||||||
| uEV-P20 | 149 (98.7%) | 30.2 | 1 | ||||||
| uEV-P150 | 109 (71.2%) | 25.74 | 1 | ||||||
© 2022 Dr. Kislinger lab